Clinical Trials Browser

Interventional × Ganglioglioma × Clear all

Astrocytoma, Brain Neoplasms, Disease, Ependymoma, Glioblastoma, Glioma, Oligodendroglioma, Ganglioglioma

NCT03975829 2026-02-13

Pediatric Long-Term Follow-up and Rollover Study

Astrocytoma, Ganglioneuroma, Glioblastoma, Glioma, Histiocytosis, Langerhans-Cell, Neuroblastoma, Neurofibromatosis 1, Oligodendroglioma, Ganglioglioma, Neurocytoma, Neurofibroma, Plexiform

NCT01288235 2025-06-03

Proton Radiotherapy for Pediatric Brain Tumors Requiring Partial Brain Irradiation

Phase 2 Completed

100 enrolled 11 charts

CNS

Astrocytoma, Brain Neoplasms, Ependymoma, Ganglioglioma

NCT02684058 2023-12-13

Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Pediatric Patients With BRAF V600 Mutation Positive LGG or Relapsed or Refractory HGG Tumors

Phase 2 Completed

151 enrolled 45 charts 1 FDA

CNS

Astrocytoma, Ganglioneuroma, Glioblastoma, Glioma, Oligodendroglioma, Ganglioglioma, Neurocytoma

NCT00003458 2022-03-07

Antineoplaston Therapy in Treating Children With Brain Tumors

Phase 2 Completed

34 enrolled 6 charts

CNSSarcoma

Astrocytoma, Craniopharyngioma, Glioblastoma, Oligodendroglioma, Neuroectodermal Tumors, Primitive, Ganglioglioma, Neurocytoma, Gliosarcoma

Clinical Trials

rQNestin

Pediatric Long-Term Follow-up and Rollover Study

Proton Radiotherapy for Pediatric Brain Tumors Requiring Partial Brain Irradiation

Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Pediatric Patients With BRAF V600 Mutation Positive LGG or Relapsed or Refractory HGG Tumors

Antineoplaston Therapy in Treating Children With Brain Tumors